Clinical updates from SGO 2023 on PARP inhibitors in ovarian cancer
touchCONGRESS for touchONCOLOGY
Listen to renowned experts in gynaecological oncology Dr Domenica Lorusso, Dr Susana Banerjee and Prof. Frederik Marmé review key data presented at SGO 2023 on recent developments in the use of PARP inhibitors in ovarian cancer. Aspects covered include first-line maintenance therapy, selection and sequencing implications, and future directions including emerging neoadjuvant and combination regimens. They also discuss how these latest data may impact clinical practice.
Clinical themes:
Update on first-line PARP inhibitor maintenance in ovarian cancer: Where are…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.